Amy Vandenberg Net Worth & Insider Trades

Amy Vandenberg - Chief Clinical & Reg Officer, Obalon Therapeutics Inc

As of January 28, 2020

What is Amy Vandenberg's Net Worth?

The current estimated net worth of Obalon Therapeutics Inc's Chief Clinical & Reg Officer, Amy Vandenberg, is estimated to be about $47.06K . Amy Vandenberg owns about 11,764 units of Obalon Therapeutics Inc common stock. In the last 4 years at Obalon Therapeutics Inc, Amy Vandenberg has sold an estimated value of $0 worth.

What is Amy Vandenberg's Past Insider Trading?

Amy Vandenberg's largest purchase order was 2,500 units , worth over $10K on August 8, 2019. In total, Amy Vandenberg has made about 11 transactions over 4 years of their time at Obalon Therapeutics Inc. Amy Vandenberg usually trades in January, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Amy Vandenberg's' Mailing Address?

  • Mailing address is C/o Obalon Therapeutics, Inc. 5421 Avenida Encinas, Suite F Carlsbad CA 92008 CA

What are Obalon Therapeutics Inc's Past Insider Trades?

Obalon Therapeutics Inc's most recent insider trade came on November 14, 2019 by William J Plovanic who bought 65,000 units worth $107.82K . In the last 3 years, insiders at Obalon Therapeutics Inc have sold an estimated value of $10K and bought an estimated value of $7.97M worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are William J Plovanic,  Amy Vandenberg, Chief Clinical & Reg Officer,  and Mark Brister, Chief Technology Officer .

OBALON THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1